Cargando…

Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association

About 75% of colorectal cancers are diagnosed as early stage, in which radical surgery is achievable. In the last decade, in Italy, the overall incidence of colorectal cancer has remained stable, while mortality gradually decreased, which is attributable to early diagnosis and improved medical, surg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvatore, Lisa, Imperatori, Marco, Arnoldi, Ermenegildo, Carnaghi, Carlo, Cordio, Stefano, Cosimelli, Maurizio, Cremolini, Chiara, Maiello, Evaristo, Martinelli, Erika, Normanno, Nicola, Sciallero, Stefania, Cannizzaro, Renato, Musio, Daniela, Cinquini, Michela, Moschetti, Ivan, Fittipaldo, Veronica Andrea, Aprile, Giuseppe, Beretta, Giordano D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709518/ https://www.ncbi.nlm.nih.gov/pubmed/33262200 http://dx.doi.org/10.1136/esmoopen-2020-001001

Ejemplares similares

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)
por: Salvatore, Lisa, et al.
Publicado: (2017)

Psychosocial Care for Adult Cancer Patients: Guidelines of the Italian Medical Oncology Association
por: Caminiti, Caterina, et al.
Publicado: (2021)

Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy
por: Ciardiello, Davide, et al.
Publicado: (2021)

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology
por: Miglietta, Federica, et al.
Publicado: (2022)

CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients
por: Napolitano, Stefania, et al.
Publicado: (2022)

Effects of goal‐oriented care for adults with multimorbidity: A systematic review and meta‐analysis
por: Barbato, Angelo, et al.
Publicado: (2022)

Speed of updating online evidence based point of care summaries: prospective cohort analysis
por: Banzi, Rita, et al.
Publicado: (2011)

Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM trial
por: Martini, Giulia, et al.
Publicado: (2023)

Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection—A systematic review and meta-analysis
por: Buonfrate, Dora, et al.
Publicado: (2018)

Clinical evidence continuous medical education: a randomised educational trial of an open access e-learning program for transferring evidence-based information – ICEKUBE (Italian Clinical Evidence Knowledge Utilization Behaviour Evaluation) – study protocol
por: Moja, Lorenzo, et al.
Publicado: (2008)

Cetuximab as third‐line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild‐type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials
por: Martini, G., et al.
Publicado: (2023)

Psychometric Properties of the Attitudes toward Self-Revised in Italian Young Adults
por: Innamorati, Marco, et al.
Publicado: (2013)

Laparoscopic treatment of ventral hernias: the Italian national guidelines
por: Campanile, Fabio Cesare, et al.
Publicado: (2023)

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents
por: Rachiglio, Anna Maria, et al.
Publicado: (2019)

Preliminary Validation of the Italian Night Eating Questionnaire (I-NEQ-16): Item Analysis and Factor Structure
por: Innamorati, Marco, et al.
Publicado: (2018)

Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE)
por: Caccialanza, Riccardo, et al.
Publicado: (2016)

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)
por: Normanno, Nicola, et al.
Publicado: (2020)

Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)

A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab
por: Bonomi, Lucia, et al.
Publicado: (2020)

Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations
por: Caccialanza, Riccardo, et al.
Publicado: (2022)

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities
por: Moretti, Anna, et al.
Publicado: (2016)

The Shifting Landscape of Genitourinary Oncology During the COVID-19 Pandemic and how Italian Oncologists Reacted: Results from a National Survey
por: Marandino, Laura, et al.
Publicado: (2020)

Insufficient uptake of systematic search methods in oncological clinical practice guideline: a systematic review
por: Trevisiol, Chiara, et al.
Publicado: (2019)

Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials
por: Ciardiello, Davide, et al.
Publicado: (2023)

COVID-19: The Italian Viral “Gerocide” of the 21 st Century
por: Servello, Adriana, et al.
Publicado: (2020)

Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement
por: Beretta, G.D., et al.
Publicado: (2022)

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC-03-2018)
por: Damato, Angela, et al.
Publicado: (2020)

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
por: Bajetta, E., et al.
Publicado: (1998)

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial
por: Martinelli, E, et al.
Publicado: (2017)

Italian Validation of the Short Version of the Failure to Mentalize Trauma Questionnaire in Adults at Risk Due to Childhood Trauma
por: Raimondi, Giulia, et al.
Publicado: (2023)

The Association among Difficulties in Emotion Regulation, Hostility, and Empathy in a Sample of Young Italian Adults
por: Contardi, Anna, et al.
Publicado: (2016)

Liposarcoma of the colon presenting as an endoluminal mass
por: D'Annibale, Marco, et al.
Publicado: (2009)

The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology
por: Queirolo, P., et al.
Publicado: (2023)

SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations—consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM)
por: Orlacchio, Antonio, et al.
Publicado: (2022)

Results of a survey on elderly head and neck cancer patients on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
por: Belgioia, Liliana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cfdtnu6o2q8o0fjip13rgegban